Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
  • Neubauer Group: Oxford Centre for Clinical Magnetic Resonance Research

    OCMR uses sophisticated cardiac MR imaging and spectroscopy methods to phenotype cardiovascular disease – in small-scale proof-of-principle studies, large-scale multicentre clinical trials and ultra-large scale population imaging programmes. As well as running their own research programmes, OCMR serves as a collaboration partner to any group wanting to strengthen their clinical research with state of the art non-invasive phenotyping tools.

  • Myerson Group: Heart Valve Disease

    We investigate diseases of the heart valves – how widespread the problem is, what the causes are, who is at risk from future problems and what treatments can improve outcomes for patients.

  • Ferreira Group: Quantitative cardiac magnetic resonance myocardial tissue characterisation

    We have expertise in the study of heart disease using cardiovascular magnetic resonance (CMR), particularly quantitative techniques such as myocardial T1-mapping.